|
|
Transcript: Commentary: Drug companies are justified in setting high prices on drugs so that they can reinvest their profits into research on new drugs, despite calls for drugs to be provided at low or no cost
- Article from:
- NPR All Things Considered
- Article date:
- March 21, 2001
- Author:
CopyrightProvided by ProQuest LLC. (Hide copyright information)
|
00-00-0000
Commentary: Drug companies are justified in setting high prices on
drugs so that they can reinvest their profits into research on new
drugs, despite calls for drugs to be provided at low or no cost
Host: LINDA WERTHEIMER
Time: 9:00-10:00 PM
LINDA WERTHEIMER, host:
How to sell new drugs and what to charge for them represents another
ethical problem to commentator Merrill Matthews. He says it's not
so easy for drug companies to offer their products to poor people
at low cost.
MERRILL MATTHEWS:
The growing AIDS crisis in Africa has put US drug companies in the
hot seat, creating for them both an ethical and an economic dilemma.
A number of ...